HighMark Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.1K | Sell |
49
-4
| -8% | -$742 | ﹤0.01% | 325 |
|
|
2025
Q1 | $14.9K | Sell |
53
-22
| -29% | -$6.18K | 0.01% | 231 |
|
|
2024
Q4 | $13.3K | Sell |
75
-4
| -5% | -$711 | 0.01% | 250 |
|
|
2024
Q3 | $15.6K | Sell |
79
-5
| -6% | -$987 | 0.01% | 233 |
|
|
2024
Q2 | $14.4K | Buy |
84
+32
| +62% | +$5.49K | 0.01% | 231 |
|
|
2024
Q1 | $9.47K | Buy |
52
+22
| +73% | +$4.01K | 0.01% | 286 |
|
|
2023
Q4 | $4.65K | Sell |
30
-91
| -75% | -$14.1K | ﹤0.01% | 379 |
|
|
2023
Q3 | $18K | Buy |
121
+105
| +656% | +$15.7K | 0.02% | 191 |
|
|
2023
Q2 | $2.16K | Hold |
16
| – | – | ﹤0.01% | 448 |
|
|
2023
Q1 | $2.55K | Hold |
16
| – | – | ﹤0.01% | 479 |
|
|
2022
Q4 | $2.59K | Sell |
16
-37
| -70% | -$5.98K | ﹤0.01% | 407 |
|
|
2022
Q3 | $7K | Buy |
53
+3
| +6% | +$396 | 0.01% | 282 |
|
|
2022
Q2 | $8K | Sell |
50
-3
| -6% | -$480 | 0.01% | 270 |
|
|
2022
Q1 | $9K | Hold |
53
| – | – | 0.01% | 277 |
|
|
2021
Q4 | $7K | Buy |
53
+3
| +6% | +$396 | ﹤0.01% | 305 |
|
|
2021
Q3 | $5K | Buy |
50
+8
| +19% | +$800 | ﹤0.01% | 345 |
|
|
2021
Q2 | $5K | Buy |
42
+1
| +2% | +$119 | ﹤0.01% | 346 |
|
|
2021
Q1 | $4K | Buy |
+41
| New | +$4K | ﹤0.01% | 350 |
|
|
2020
Q4 | – | Sell |
-166
| Closed | -$15K | – | 441 |
|
|
2020
Q3 | $15K | Buy |
166
+2
| +1% | +$181 | 0.01% | 185 |
|
|
2020
Q2 | $16K | Buy |
+164
| New | +$16K | 0.02% | 151 |
|
|
2020
Q1 | – | Sell |
-202
| Closed | -$17K | – | 351 |
|
|
2019
Q4 | $17K | Buy |
+202
| New | +$17K | 0.02% | 144 |
|